Extract
In the European Respiratory Journal, Albert et al. [1] reviewed the lessons learnt from the global roll-out of Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) highlighting the need, among others, to build country capacity to ensure an impactful introduction of new diagnostic technologies.
Abstract
Improving availability, accessibility and quality of national GeneXpert networks through ASAP-GxNet http://ow.ly/umaZ30mGRpE
Support statement
ASAP-GxNet is supported by the Stop TB Partnership's TB REACH initiative, and is funded by the Government of Canada and the Bill and Melinda Gates Foundation.
Footnotes
Conflict of interest: R. Alagna has nothing to disclose.
Conflict of interest: T.L. Sawadogo has nothing to disclose.
Conflict of interest: A. Combary has nothing to disclose.
Conflict of interest: S. Diandé has nothing to disclose.
Conflict of interest: D.M. Cirillo has nothing to disclose.
- Received September 7, 2018.
- Accepted October 11, 2018.
- Copyright ©ERS 2019
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.